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Although acini are the determining structures of tear 
fluid production, a secretory role of ducts in addition to their 
drainage function has been suspected for a long time [1,2]. 
Accumulating evidence suggests that the lacrimal gland (LG) 
duct system may modify the compositions of the primary 
acinar fluid [3,4]. Our previous experimental results provided 
direct evidence of the active role of the LG duct system in 
lacrimal fluid secretion [5]. Investigation of the underlying 
mechanisms revealed several components, but the regulation 
of ductal fluid secretion is still not fully understood. Previous 
reports demonstrated the contribution of vasoactive intestinal 
peptide (VIP) released by parasympathetic nerves in acinar 
protein secretion, but its impact on the fluid secretion of the 
LG ducts remained unknown [6]. VIP has been shown as 
a smooth-muscle-relaxant, vasodilator peptide in the lung 
[7], but it is also an important regulator of tear production in 
humans. This was illustrated by a case report of a patient who 
had a VIP-secreting metastatic pancreatic adenocarcinoma. 
With an 80-fold elevation of serum VIP levels, this patient 
had tear overproduction indicating that VIP increases tear 
secretion in humans, most likely by stimulating LG fluid 
secretion [8]. There are two known receptors for VIP termed 
VPAC1 and VPAC2 [9-11]. Both receptors bind VIP and 
pituitary adenylate cyclase-activating polypeptide (PACAP) 
to some degree. The VIP–receptor interaction activates the G 
protein Gsα that stimulates adenylyl cyclase, which increases 
the intracellular cAMP level. cAMP, in turn, activates protein 
kinase A that stimulates secretion by phosphorylating its 
target proteins. Hodges and coworkers suggested that most, 
but not all, of VIP-stimulated protein secretion is cAMP 
dependent. Using a myristoylated protein kinase A peptide 
inhibitor (PKI) based on the pseudosubstrate of protein 
kinase A, VIP-stimulated protein secretion was shown to be 
inhibited by about 70% [6].
Several hormones and neurotransmitters (including VIP) 
with the potential to elevate cytosolic cAMP level can acti-
vate the cystic fibrosis transmembrane conductance regulator 
(CFTR) channel. Our previous findings strongly suggested 
the role of CFTR in ductal fluid secretion [12]. CFTR has 
been shown to play a critical role in exocrine glands, such as 
the pancreas, salivary, sweat glands, and airways epithelium 
[13-15]. Furthermore, there are several data about altered tear 
secretion seen in patients with cystic fibrosis implying the 
potential influence of CFTR [16,17]. Accumulating evidence 
from gene expression studies performed on rat and rabbit LGs 
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Purpose: Vasoactive intestinal peptide (VIP) is an important regulator of lacrimal gland (LG) function although the 
effect of VIP on ductal fluid secretion is unknown. Therefore, the aim of the present study was to investigate the role 
of VIP in the regulation of fluid secretion of isolated LG ducts and to analyze the underlying intracellular mechanisms.
Methods: LGs from wild-type (WT) and cystic fibrosis transmembrane conductance regulator (CFTR) knockout (KO) 
mice were used. Immunofluorescence was applied to confirm the presence of VIP receptors termed VPAC1 and VPAC2 
in LG duct cells. Ductal fluid secretion evoked by VIP (100 nM) was measured in isolated ducts using videomicroscopy. 
Intracellular Ca2+ signaling underlying VIP stimulation was investigated with microfluorometry.
Results: VIP stimulation resulted in a robust and continuous fluid secretory response in isolated duct segments origi-
nated from WT mice. In contrast, CFTR KO ducts exhibited only a weak pulse-like secretion. A small but statistically 
significant increase was detected in the intracellular Ca2+ level [Ca2+]i during VIP stimulation in the WT and in CFTR 
KO ducts. VIP-evoked changes in [Ca2+]i did not differ considerably between the WT and CFTR KO ducts.
Conclusions: These results suggest the importance of VIP in the regulation of ductal fluid secretion and the determining 
role of the adenylyl cyclase-cAMP-CFTR route in this process.
Cor respondence to: Edit Tóth-Molnár Depar tment of 
Ophthalmology University of Szeged 10-11 Korányi fasor Szeged, 
H-6720, Hungary; Phone: +36308864894; email: tme@tmedit.hu
Molecular Vision 2020; 26:780-788 <http://www.molvis.org/molvis/v26/780> © 2020 Molecular Vision 
781
demonstrated the predominant expression of CFTR in LG 
duct cells [3,18]. The main role of CFTR is regulated anion 
conductance in the apical membrane of many different epithe-
lial cell types. Regulation of channel activity is predomi-
nantly via cAMP/protein kinase A signaling [19,20]. The aim 
of the study was to determine the effect of VIP on ductal fluid 
secretion and to reveal the underlying mechanisms of VIP 
stimulation. Parts of the results in this manuscript have been 
presented in abstracts in the Annual Meeting of the Associa-
tion for Research in Vision and Ophthalmology [21].
METHODS
Animals: CFTR knockout (KO) mice were used throughout 
the experiments [22,23]. The mice were congenic on the 
FVB/N background. Wild-type (WT) refers to the +/+ litter-
mates of the CFTR KO mice. The mice used in this study 
were 14–16 weeks old and weighed 18–22 g. The gender ratio 
was 1:1 for all groups. Animals were narcotized intraperito-
neally with ketamine (80 mg/kg) and xylazine (10 mg/kg) and 
euthanized with pentobarbital overdose (100 mg/kg).
All experiments were conducted in compliance with the 
ARVO Statement for the Use of Animals in Ophthalmic and 
Vision Research. The protocol was approved by the Ethical 
Committee for the Protection of Animals in Research of the 
University of Szeged (Szeged, Hungary) and conformed to the 
Directive 2010/63/EU of the European Parliament and to the 
Hungarian Government Decree 40/2013 (II:14.). Breeding of 
gene-modified mice was approved under the permission No. 
XXII./2116/2018.
Solutions and chemicals: The compositions of solutions (for 
isolation, storage, and culture of isolated duct segments) 
used in the present studies are summarized in Table 1. Media 
supplements (Dulbecco's modified eagle medium [DMEM], 
McCoy, fetal calf serum [FCS], glutamine, and bovine serum 
albumin [BSA]), VIP, carbachol (carbamoylcholine chloride) 
and 1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetra-acetic 
acid (BAPTA-AM) were purchased from Sigma-Aldrich 
(Budapest, Hungary). The standard HCO3
–/CO2 buffered 
solution was gassed with 95% O2/5% CO2 at 37 °C. FURA2 
AM was purchased from Invitrogen (Waltham, MA).
Immunofluorescence: Immunofluorescence was used to 
confirm the presence of VPAC1 and VPAC2 receptors in 
the LG. A detailed description of the method was given 
previously by our laboratory [12]. Fifteen μm thick cryostat 
sections were rehydrated by washing in tris-buffered saline 
(TBS, 20 mM Tris-HCl pH:7.5, 150 mM NaCl) for 5 min, 
then fixed in 2% paraformaldehyde (PFA). After washing 
the sections in TBS three times for 5 min each, the samples 
were permeabilized with 0,1% Triton-X in TBS for 10-15 min. 
The sections were blocked with 5% FCS in TBS for 1 h at 
room temperature followed by an overnight incubation with 
primary antibodies for for VPAC1 (1:1000) or VPAC2 (1:250, 
Abcam, Cambridge, UK) at 4 °C. The next day the samples 
were incubated with secondary antibody, Alexa-488 conju-
gated goat anti-rabbit (1:1000, Abcam) for 1 hour and Hoechst 
(1:1000, Sigma-Aldrich) for 20 min at room temperature. The 
samples were examined under a Zeiss LSM 880 confocal 
laser scanning microscope (Oberkochen, Germany). Images 
were analyzed with ImageJ (NIH, Bethesda, MD).











NaCl (mM) 115    
KCl (mM) 5    
MgCl2 (mM) 1    
CaCl2 (mM) 1    
D-Glucose (mM) 10    
NaHCO3 (mM) 25    
Dulbecco’s Modified Eagle Medium  X X  
Collagenase (U/ml)  100   
BSA (mg/ml)  1 0.03  
McCoy’s 5A Tissue Culture Medium    X
Fetal calf serum, (vol/vol %)    10
Glutamine (mM)    2
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Isolation and culture of lacrimal duct segments: Mouse LG 
interlobular ducts were isolated as previously described by 
our laboratory [4]. In brief, LG was dissected and transferred 
to a sterile flat-bottom glass flask containing storage solution 
(4 ºC). Isolation solution was injected into the LG tissue and 
the pieces were transferred to a glass flask containing 2 ml 
of isolation solution for incubation in a shaking water bath 
at 37 ºC Isolation solution was removed after incubating for 
25 min and 5 ml of fresh storage solution (4 ºC) was added 
to the flask. LG tissues were then transferred onto a glass 
microscope slide, and interlobular ducts were micro-dissected 
under a stereomicroscope and then transferred to the culture 
solution in a Petri dish. Isolated ducts were cultured overnight 
in a 37 °C incubator gassed with 5% CO2.
Measurement of ductal fluid secretion: The videomicroscopic 
technique was used for the measurement of duct fluid secre-
tion. The method was originally developed for the measure-
ment of pancreatic duct fluid secretion and was modified 
by our laboratory for the investigation of LG duct secretion 
[5,24].
Measurement of intracellular Ca2+ concentration: Intracel-
lular Ca2+ concentration [Ca2+]i was measured using Ca
2+-
sensitive fluorescent dye FURA2 AM (4–5 μM) as described 
[4]. Changes in [Ca2+]i were measured using an imaging 
system (Xcellence; Olympus, Budapest, Hungary). Four to 
five small areas (regions of interests [ROIs]) of five to ten 
cells were excited in each intact duct with light at 340 and 
380 nm, and the 380/340 fluorescence emission ratio was 
measured at 510 nm. Results are expressed as the maximum 
value of the 380/340 fluorescence emission ratio [Fmax (380/340)]. 
One [Ca2+]i measurement was obtained per second.
Statistical analysis: A mixed analysis of variance (ANOVA) 
model was applied for the calculation of ductal fluid secre-
tion. Effects of the stimulatory compound (VIP) were taken 
into account as fixed effects. The effect of the individual duct 
and the duct and effects of VIP interaction (we assumed that 
the value of the effect of the stimulatory compounds depends 
on the individual duct) were taken into account as random 
effects in the model. Statistical software (SigmaPlot Systat; 
Software, Inc., London, England) was used to analyze the 
data, which were presented as means ± standard error of the 
mean (SEM). A p value of less than 0.05 was regarded as 
statistically significant.
RESULTS
Immunofluorescence: The presence of VPAC1 was dominant 
in the duct cells as demonstrated in Figure 1. The receptor 
was localized on the basolateral surface of the duct cells. 
Immunofluorescence staining of VPAC1 receptors revealed a 
mosaic pattern among different duct segments in the expres-
sion of the receptor proteins. The intensity of the fluorescence 
varied widely in the investigated duct segments from intense 
immunofluorescence to a lack of staining. No difference was 
detected in the immunoreactivity between the LG tissues 
from the WT and CFTR KO mice.
Intense VPAC2 staining was detected not only in the duct 
cells but also in the basolateral surface of the acinar cells 
(Figure 2). The intensity of the immunofluorescence staining 
was similar in the case of the WT and CFTR KO LGs.
VIP-induced fluid secretion in isolated LG ducts: The effect 
of VIP (100 nM) on ductal fluid secretion was investigated in 
WT and CFTR KO mouse LG ducts. A remarkable proportion 
of isolated ducts failed to react to the applied agent. These 
findings are in accordance with the results in the VPAC1 
immunofluorescence studies in which the expression of the 
receptor protein showed a mosaic pattern, and the fluctua-
tion of the presence of VPAC1 predicted a widely altering 
response of different duct segments to VIP stimulation. Obvi-
ously, all data displayed in this section were obtained from 
the reacting (i.e., responding with a swelling reaction) ducts.
The concentration of VIP was 100 nM in these experi-
ments. This value was determined based on data from the 
literature and on our preliminary experiments in which higher 
concentrations of VIP (200 and 500 nM) did not result in 
greater effects compared to the 100 nM concentration (results 
are not shown). The VIP stimulation (100 nM) resulted in a 
robust and continuous fluid secretory response in isolated LG 
duct segments derived from WT mice (the secretory rate in 
the first 10 min of stimulation was 213.1±37.30 pl/min/mm2, 
n = 7; Figure 3A). In contrast, the CFTR KO ducts exhibited 
only a weak pulse-like secretion in the first 5 min of stimula-
tion (54.5±18.4 pl/min/mm2, n = 6), followed by a plateau 
(Figure 3B). The VIP-induced luminal volume changes in the 
WT and CFTR KO ducts observed during the videomicro-
scopic experiments are shown in Figure 4.
VIP-induced Ca2+ signaling of isolated LG ducts: The CFTR 
KO ducts exhibited only a weak pulse-like secretion during 
VIP stimulation. We hypothesized in the background of this 
phenomenon that in addition to lacking the cAMP-CFTR 
pathway VIP stimulation may induce changes in [Ca2+]I, 
and this latter intracellular mechanism may also contribute 
to the fluid secretion of ducts. Therefore, in the next series 
of experiments possible effects of VIP stimulation on [Ca2+]
i were measured.
Intracellular Ca2+ homeostasis underlying VIP stimu-
lation was measured in WT and CFTR KO duct segments. 
VIP stimulation (100 nM) resulted in a small but statistically 
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significant increase in [Ca2+]i in the WT (11.6±0.70%, p = 
0.001, n = 6) and CFTR KO ducts (11.1±0.50%, p = 0.002, n 
= 6; Figure 5). Cholinergic agonist carbachol (100 µM) was 
used as positive control in these experiments. The selection 
of the 100 µM concentration for carbachol was based on our 
previous experiments where a definite dose–response relation 
was observed in the 1–100 µM concentration range [12].
VIP-induced fluid secretion in the presence of intracellular 
Ca2+-chelator BAPTA-AM in LG ducts isolated from CFTR 
KO mice: To analyze the role of Ca2+ signaling in VIP-
induced ductal fluid secretion, the effect of VIP stimulation 
was investigated in the presence of intracellular Ca2+-chelator 
BAPTA-AM. In these fluid secretion experiments, isolated 
ducts were preincubated with BAPTA-AM (10 µM) for 30 
min before application of VIP (100 nM). A total of eight ducts 
Figure 1. Immunof luorescence 
staining of VPAC1 receptors in 
lacrimal gland tissues of WT and 
CFTR KO mice. VPAC1 staining 
was more intense in ducts (d) 
than in acinar (ac) cells. A mosaic 
pattern was observed in the expres-
sion of the receptor proteins in 
different ducts. The intensity of 
the fluorescence varied widely in 
the investigated duct segments 
from intense immunofluorescence 
to a lack of staining. There were 
no statistically significant differ-
ences between the wild-type (WT) 
and cystic fibrosis transmembrane 
conductance regulator (CFTR) 
knockout (KO) samples. Hoechst 
dye was used to stain nuclei blue.
Figure 2. Immunof luorescence 
staining of VPAC2 receptors in 
lacrimal gland tissues of WT and 
CFTR mice. VPAC2 was observed 
on the basolateral surface of duct 
(d) and acinar (ac) cells. There were 
no significant differences between 
the wild-type (WT) and cystic 
fibrosis transmembrane conduc-
tance regulator (CFTR) knockout 
(KO) samples. Hoechst dye was 
used to stain nuclei blue.
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isolated from three CFTR KO animals were investigated 
in these series of experiments. Following the BAPTA-AM 
preincubation, VIP failed to elicit an increase in secretion in 
any of the ducts (Figure 3B). The secretory rates were similar 
to the control values (i.e., no secretion was detected either 
in the BAPTA-AM+VIP or in the control ducts). A curve 
showing the secretory response of the BAPTA-AM+VIP-
treated CFTR KO ducts appeared to be identical to the control 
curves; therefore, the results of the control experiments are 
not shown in Figure 3B.
Figure 3. Effect of VIP stimulation 
on ductal fluid secretion in isolated 
lacrimal gland ducts from WT and 
CFTR KO mice. A: The wild-type 
(WT) ducts were exposed either 
to 100 nM vasoactive intestinal 
peptide (VIP; filled rhombus) or 
to no agonist (empty triangle). B: 
The cystic fibrosis transmembrane 
conductance regulator (CFTR) 
knockout (KO) ducts were exposed 
either to 100 nM VIP (filled square) 
or to 100 nM VIP following 10 
µM 1,2-bis(o -aminophenoxy)
ethane-N,N,N′,N′-tetra-acetic acid 
(BAPTA-AM) pretreatment (empty 
triangle). Changes in relative 
luminal volume (Vr) are shown. Data were obtained from six to eight ducts isolated from three different animals in each series and are 
presented as means ± standard error of the mean (SEM).
Figure 4. Representative photo 
series of secreting isolated lacrimal 
gland duct segments in response 
to VIP stimulation. The luminal 
spaces of the native images (first 
and third rows) are marked with 
blue (second and fourth rows). A 
strong secretory response could 
be shown in wild-type (WT) ducts 
to vasoactive intestinal peptide 
(VIP) stimulation as the luminal 
spaces were notably swollen after 
treatment. No remarkable changes 
could be detected in cystic fibrosis 
transmembrane conductance regu-
lator (CFTR) knockout (KO) ducts 
following VIP stimulation.
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DISCUSSION
In the last two decades, results of gene expression studies 
reaffirmed previous suggestions about the secretory role of 
LG duct epithelial cells, because greater expression of a wide 
range of transmembrane transporters could be demonstrated 
in the duct cells compared to acinar cells [3,25-27]. Although 
these results were important steps toward the clarification of 
duct cell function, they were unable to provide direct func-
tional evidence. Our laboratory developed the first experi-
mental model suitable for the investigation of lacrimal duct 
function which opened a new path in lacrimal duct research. 
Our efforts are directed toward the clarification of the role 
of LG ducts in the secretory process of the gland using this 
isolated duct model [4,5]. These viable duct segments are 
appropriate models not only for the investigation of the func-
tion of transmembrane transporters but also for the investiga-
tion of the regulation of secretory machinery. Although the 
secretory process of the duct epithelium may play an impor-
tant role in tear production, our knowledge about the regula-
tion of lacrimal duct function is limited. Tear secretion is 
mediated mainly by the parasympathetic system [28,29]. The 
anatomically and functionally predominant parasympathetic 
nerves can be subdivided into two different branches based 
on the secreted neurotransmitters. Cholinergic nerve endings 
release the cholinergic agonist acetylcholine, while VIP-ergic 
nerve terminals produce VIP. Both neurotransmitters have 
major effects on the secretion of the LG [28]. The available 
experimental evidence for the role of the parasympathetic 
system in LG fluid secretion is solely from intact glands or 
acini. We investigated the direct effect of VIP-ergic stimuli 
on isolated LG duct segments and explored the relation-
ship between the CFTR chloride channel and the VIP-ergic 
signaling pathway.
Immunofluorescence was used to confirm the pres-
ence and localization of VPAC1 and VPAC2 proteins on LG 
duct cells in WT and CFTR KO mice. A previous report by 
Hodges et al. showed the presence of these receptors with 
immunostaining on the basolateral surface of acinar and duct 
cells in rats [6]. An apparent difference was revealed in the 
distribution of VPAC1 and VPAC2 receptors in mouse LG 
in the present study. The presence of VPAC1 was proved 
predominantly in ducts with immunoreactivity. In addition to 
the characteristically ductal localization of VPAC1 receptors, 
a mosaic pattern in the expression of the receptor proteins was 
revealed. The intensity of the immunofluorescence varied on 
a wide scale from intense staining to almost complete unde-
tectability in the analyzed duct segments. VPAC2 showed a 
more homogeneous distribution in LG tissue: These recep-
tors were traceable in acinar and duct cells. VPAC1 and 
VPAC2 were observed most prominently on the basolateral 
membrane of mouse LG cells. Expression patterns of VPAC1 
and VPAC2 receptors differ from the presence of CFTR in 
mouse LG. The CFTR protein was predominant in ducts in 
contrast to the VPAC2 receptors, while CFTR expression 
Figure 5. Effects of VIP and carba-
chol on [Ca2+]i in lacrimal gland 
duct cells from WT and CFTR KO 
mice. A: Representative record-
ings of the microf luorescence 
experiments: Effects of vasoactive 
intestinal peptide (VIP; 100 nM) on 
[Ca2+]i in lacrimal gland duct cells 
from wild-type (WT) and cystic 
fibrosis transmembrane conduc-
tance regulator (CFTR) knockout 
(KO) mice (panel A, left curve). 
Carbachol (100 µM) was used for 
comparison, as a positive control, 
in these experiments (panel A, 
right curve). F380/340: 380/340 nm 
fluorescence emission ratio. B: Maximum values of the 380/340 nm fluorescence emission ratios. Fmax(380/340): maximum value of the 380/340 
nm fluorescence emission ratio.
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showed a reasonably homogeneous distribution in the duct 
system in contrast to the VPAC1 receptors [12,18,25]. A 
connection between CFTR and VPACs at the protein expres-
sion level also seems implausible, as the lack of CFTR did not 
influence the expression of VPAC1 and VPAC2 proteins: No 
difference was detected between the immunoreactivity of the 
WT and CFTR KO LG tissues in the experiments.
To explore the fluid secretory effect of VIP, videomicro-
scopic experiments were applied. VIP (100 nM) stimulation 
caused strong and continuous fluid secretion in the ducts 
from the WT mice. In contrast, as a result of VIP stimulation, 
the CFTR KO ducts exhibited only weak pulse-like secretion 
in the first 5 min, followed by a plateau. These findings are 
substantially different from the results we obtained previ-
ously in carbachol stimulated experiments where identical 
ductal fluid secretory responses were observed in the WT 
and CFTR KO mouse LG ducts [12]. The observed reduction 
in response to VIP stimulation in CFTR KO ducts may be 
explained by the lack of CFTR rather than changes in VPAC1 
and VPAC2, as no difference was detected in the density of 
the VIP receptors between the WT and CFTR KO ducts in 
the present immunofluorescence studies. The role of CFTR 
can be explained by the following chain of effects: Stimula-
tion of VIP receptors increases the intracellular cAMP levels 
via adenylyl-cyclase, and then cAMP (as a potent activator) 
increases the activity of CFTR. Therefore, this transporter 
seems to be the determining component of the robust fluid 
secretion evoked by VIP in WT ducts. The weak secretory 
response observed in the CFTR KO ducts during VIP stimu-
lation seems to confirm the described mechanism.
Ca2+ homeostasis underlying VIP stimulation and the 
potential role of CFTR protein was also investigated. The 
effect of VIP stimuli on the cytosolic Ca2+ signaling was 
measured with microfluorometry. VIP acts not only through 
the adenylyl cyclase-cAMP system, but also, to a smaller 
extent, VIP elevates [Ca2+]i . VIP-evoked elevations of [Ca
2+]
i were also independent from the presence of CFTR and did 
not differ in the WT and CFTR KO ducts in a significant 
manner. Therefore, VIP stimulation had a similar effect on 
[Ca2+]i compared to the results of our previous experiments 
using carbachol stimulation. In those experiments, identical 
changes of [Ca2+]i were found in WT and CFTR KO mouse 
LG ducts [12]. However, the elevations in [Ca2+]i were 
much smaller in the case of VIP stimulation compared to 
the effect of carbachol. The role of these VIP-induced small 
changes of [Ca2+]i was further investigated in fluid secretion 
experiments where intracellular Ca2+-chelator BAPTA was 
applied. In a short series of preliminary experiments, WT 
ducts were incubated with BAPTA-AM (data not shown). 
No effect of the BAPTA-AM pretreatment on the robust VIP 
stimulated swelling response of WT ducts was detectable. 
The lack of demonstrability of the BAPTA-AM effect in the 
wild-type ducts can be explained by the sensitivity of the 
applied videomicroscopic method combined with the negli-
gible effect of Ca2+-dependent mechanisms in addition to the 
robust cAMP-dependent effect. In the next series of experi-
ments, ducts isolated from CFTR KO mice were incubated 
with BAPTA before VIP stimulation. The suspended Ca2+ 
signaling completely abolished the remaining VIP-induced 
secretory response of mouse LG ducts lacking the cAMP-
CFTR pathway. These results strongly suggest the minor 
complementary role of Ca2+-regulated mechanisms in VIP-
induced ductal fluid secretion. However, there is one detail 
that must be taken into consideration regarding these results: 
According to the mosaic pattern of VPAC1 receptors in the 
different duct segments, a remarkable portion of isolated 
ducts (approximately 50%–65% of all ducts in to complete 
series of all experiments) failed to react to VIP. This result 
suggests caution in the interpretation of negative results (i.e., 
non responding ducts). However, we performed a relatively 
high number of experiments in these series: eight ducts 
isolated from three different animals were investigated. We 
believe that this number makes our conclusions plausible 
and minimizes the probability of a random series of all non-
responding ducts.
Findings in our previous experiments studying effects 
of carbachol stimulation and the present results in immunos-
taining studies and in fluid secretion together with [Ca2+]i 
experiments suggest two partially independent parasympa-
thetic regulatory pathways. Briefly, carbachol stimulation 
acts solely through elevation of [Ca2+]I, and it does not involve 
the adenylyl cyclase-cAMP route. Consequently, CFTR is not 
involved in carbachol-stimulated fluid secretion as it is acti-
vated by cAMP. For VIP stimuli, [Ca2+]i was slightly elevated 
without a significant difference between the values measured 
in the WT and CFTR KO ducts. However, the secretory 
response of the LG ducts showed a large significant differ-
ence in the WT and CFTR KO ducts: the rate of fluid secre-
tion of the CFTR KO ducts was far below the value obtained 
in the WT ducts. These data prove the determining role of 
the adenylyl cyclase-cAMP-CFTR route in VIP-stimulated 
fluid secretion of LG ducts. Results of the VIP experiments 
are in accordance with previous observations that VIP acts 
predominantly through elevation of the cytosolic cAMP level, 
and only a small part of the action of VIP is thought to be 
mediated by Ca2+ signaling [30,31]. The lack of functionally 
active CFTR seen in the CFTR KO mice influences the VIP-
induced secretory response of LG ducts and thus, can modify 
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the total parasympathetic-evoked secretory contribution of 
the LG.
The observed VIP-induced significant fluid secretion 
suggests the importance of this neurotransmitter in the regu-
lation of the duct system. LG duct cells have several different 
Cl- and K+ selective ion channels and transporters located on 
the basolateral and apical membranes. Elevated cytosolic 
cAMP levels and intracellular Ca2+ signaling can activate 
Cl- and K+ secretion through these channels and transporters. 
VIP seems to have target structures in basolateral and apical 
membranes. Previously, we reported the strong stimulatory 
effect of cell-permeable cAMP-analogue 8-bromo cAMP 
and VIP on basolaterally located sodium-potassium-chloride 
cotransporter type 1 (NKCC1) [32]. The present results 
suggest the important role of VIP in the regulation of apically 
located CFTR. Therefore, VIP seems to be able to activate 
Cl- transport on the basolateral and apical sides of LG duct 
cells. In summary, actions of Cl- selective channels located 
on the basolateral and apical membranes of duct cells result 
in intraluminal f lux of Cl-. Elevation of intraluminal Cl- 
concentration is the main determinant of the lumen-negative 
transepithelial voltage difference, which is the driving force 
of ductal fluid secretion. Consequently, these results strongly 
suggest the important role of VIP in the regulation of lacrimal 
duct fluid secretion.
Identifying the mechanism underlying the regulation of 
ductal fluid transport is likely to be pertinent for treating 
ocular diseases. This study contributes to this objective by 
demonstrating that VIP-induced increases in cAMP followed 
by stimulation of CFTR chloride channel activity in the 
ductal epithelial cells drives fluid from the interstitium into 
the ductal lumen. This finding is relevant because treatment 
of some desiccating ocular surface diseases may benefit from 
applying cAMP mobilizing agents that, in turn, optimize this 
secretory process.
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